FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2153475493> ?p ?o ?g. }

• W2153475493 endingPage "496" @default.
• W2153475493 startingPage "487" @default.
• W2153475493 abstract "This study sought to predict the value of tumor marker carbohydrate antigen 125 (CA125) before and after transcatheter aortic valve implantation (TAVI) for all-cause death and a composite endpoint of death, admission for heart failure, myocardial infarction, and stroke (major adverse cardiac events [MACE]). Risk stratification after TAVI remains challenging. The use of biomarkers in this setting represents an unmet need. CA125 was measured in 228 patients before and after TAVI. The association with outcomes was assessed using parametric Cox regression and joint modeling for baseline and longitudinal analyses, respectively. CA125 was evaluated as logarithm transformation and dichotomized by its median value (M1 ≤15.7 U/ml vs. M2 >15.7 U/ml). At a median follow-up of 183 days (interquartile range: 63 to 365) and 144 days (interquartile range: 56 to 365), 50 patients (22%) died and 75 patients (33%) experienced MACE. A 3-fold increase in the rates for death and MACE was observed in patients above the median (M2 vs. M1) of CA125 (5.2 vs. 1.6 per 10 person-years and 8.3 vs. 3.3 per 10 person-years, respectively; p for both <0.001). In a multivariable analysis adjusted for logistic EuroSCORE, New York Heart Association functional class III/IV, and device success, baseline values of CA125 (M2 vs. M1) independently predicted death (hazard ratio [HR]: 2.18; 95% confidence interval [CI]: 1.11 to 4.26; p = 0.023) and MACE (HR: 1.77; 95% CI: 1.05 to 2.98; p = 0.031). In the longitudinal analysis, lnCA125 as a time-varying exposure, was highly associated with both endpoints: HR: 1.47; 95% CI: 1.01 to 2.14; p = 0.043 and HR: 2.26; 95% CI: 1.28 to 3.98; p = 0.005, for death and MACE, respectively. Serum levels of CA125 before and after TAVI independently predict death and MACE." @default.
• W2153475493 created "2016-06-24" @default.
• W2153475493 creator A5002949994 @default.
• W2153475493 creator A5003272933 @default.
• W2153475493 creator A5005713185 @default.
• W2153475493 creator A5010903743 @default.
• W2153475493 creator A5015895836 @default.
• W2153475493 creator A5019360089 @default.
• W2153475493 creator A5026443720 @default.
• W2153475493 creator A5030544709 @default.
• W2153475493 creator A5039483633 @default.
• W2153475493 creator A5043444006 @default.
• W2153475493 creator A5045053156 @default.
• W2153475493 creator A5084062450 @default.
• W2153475493 date "2013-05-01" @default.
• W2153475493 modified "2023-10-16" @default.
• W2153475493 title "Tumor Marker Carbohydrate Antigen 125 Predicts Adverse Outcome After Transcatheter Aortic Valve Implantation" @default.
• W2153475493 cites W182356710 @default.
• W2153475493 cites W1846287826 @default.
• W2153475493 cites W1984411146 @default.
• W2153475493 cites W1984472451 @default.
• W2153475493 cites W2014163754 @default.
• W2153475493 cites W2024788191 @default.
• W2153475493 cites W2032848846 @default.
• W2153475493 cites W2052953200 @default.
• W2153475493 cites W2061724830 @default.
• W2153475493 cites W2071621271 @default.
• W2153475493 cites W2094114209 @default.
• W2153475493 cites W2099528624 @default.
• W2153475493 cites W2099663735 @default.
• W2153475493 cites W2108007523 @default.
• W2153475493 cites W2115859167 @default.
• W2153475493 cites W2118196805 @default.
• W2153475493 cites W2119070520 @default.
• W2153475493 cites W2121947900 @default.
• W2153475493 cites W2127688157 @default.
• W2153475493 cites W2129975031 @default.
• W2153475493 cites W2134526322 @default.
• W2153475493 cites W2149609916 @default.
• W2153475493 cites W2151736360 @default.
• W2153475493 cites W2153820409 @default.
• W2153475493 cites W2156202966 @default.
• W2153475493 cites W2165258820 @default.
• W2153475493 cites W2166973706 @default.
• W2153475493 cites W2168001271 @default.
• W2153475493 cites W4229755335 @default.
• W2153475493 doi "https://doi.org/10.1016/j.jcin.2013.02.006" @default.
• W2153475493 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23702013" @default.
• W2153475493 hasPublicationYear "2013" @default.
• W2153475493 type Work @default.
• W2153475493 sameAs 2153475493 @default.
• W2153475493 citedByCount "29" @default.
• W2153475493 countsByYear W21534754932013 @default.
• W2153475493 countsByYear W21534754932014 @default.
• W2153475493 countsByYear W21534754932015 @default.
• W2153475493 countsByYear W21534754932016 @default.
• W2153475493 countsByYear W21534754932017 @default.
• W2153475493 countsByYear W21534754932018 @default.
• W2153475493 countsByYear W21534754932019 @default.
• W2153475493 countsByYear W21534754932020 @default.
• W2153475493 countsByYear W21534754932023 @default.
• W2153475493 crossrefType "journal-article" @default.
• W2153475493 hasAuthorship W2153475493A5002949994 @default.
• W2153475493 hasAuthorship W2153475493A5003272933 @default.
• W2153475493 hasAuthorship W2153475493A5005713185 @default.
• W2153475493 hasAuthorship W2153475493A5010903743 @default.
• W2153475493 hasAuthorship W2153475493A5015895836 @default.
• W2153475493 hasAuthorship W2153475493A5019360089 @default.
• W2153475493 hasAuthorship W2153475493A5026443720 @default.
• W2153475493 hasAuthorship W2153475493A5030544709 @default.
• W2153475493 hasAuthorship W2153475493A5039483633 @default.
• W2153475493 hasAuthorship W2153475493A5043444006 @default.
• W2153475493 hasAuthorship W2153475493A5045053156 @default.
• W2153475493 hasAuthorship W2153475493A5084062450 @default.
• W2153475493 hasBestOaLocation W21534754931 @default.
• W2153475493 hasConcept C119060515 @default.
• W2153475493 hasConcept C126322002 @default.
• W2153475493 hasConcept C141071460 @default.
• W2153475493 hasConcept C164705383 @default.
• W2153475493 hasConcept C207103383 @default.
• W2153475493 hasConcept C2780400711 @default.
• W2153475493 hasConcept C2780739214 @default.
• W2153475493 hasConcept C44249647 @default.
• W2153475493 hasConcept C500558357 @default.
• W2153475493 hasConcept C50382708 @default.
• W2153475493 hasConcept C71924100 @default.
• W2153475493 hasConceptScore W2153475493C119060515 @default.
• W2153475493 hasConceptScore W2153475493C126322002 @default.
• W2153475493 hasConceptScore W2153475493C141071460 @default.
• W2153475493 hasConceptScore W2153475493C164705383 @default.
• W2153475493 hasConceptScore W2153475493C207103383 @default.
• W2153475493 hasConceptScore W2153475493C2780400711 @default.
• W2153475493 hasConceptScore W2153475493C2780739214 @default.
• W2153475493 hasConceptScore W2153475493C44249647 @default.
• W2153475493 hasConceptScore W2153475493C500558357 @default.
• W2153475493 hasConceptScore W2153475493C50382708 @default.
• W2153475493 hasConceptScore W2153475493C71924100 @default.
• W2153475493 hasIssue "5" @default.

• next